NBA prospect Jonathan Jeanne’s career could be in jeopardy after a medical diagnosis.
According to a report from The Vertical, the 7-foot-2 French center’s agent, Bouna Ndiaye, informed the site that Jeanne has been diagnosed with Marfan syndrome.
Jeanne learned of his diagnosis after an MRI at the NBA Combine noticed an abnormality and the Cleveland Clinic determined he had the genetic disorder.
Marfan syndrome is described as:
A genetic disorder that affects the body’s connective tissue. Connective tissue holds all the body’s cells, organs and tissue together. It also plays an important role in helping the body grow and develop properly.
About 1 in 5,000 people have Marfan syndrome, including men and women of all races and ethnic groups. About 3 out of 4 people with Marfan syndrome inherit it, meaning they get the genetic mutation from a parent who has it. But some people with Marfan syndrome are the first in their family to have it; when this happens it is called a spontaneous mutation. There is a 50 percent chance that a person with Marfan syndrome will pass along the genetic mutation each time they have a child.
The 19-year-old Jeanne had been playing professional basketball overseas. There is no word on whether he will receive medical clearance from the NBA or if he will ever be able to resume his career.
Jeanne was a projected first-round pick.
If Jeanne needs any motivation to get through the diagnosis and continue hope that he could one day return to the sport he loves, he has to look no further than former Baylor star Isaiah Austin who was diagnosed with Marfan syndrome in 2014 before being cleared to return to basketball in 2016.